Thu, October 3, 2024
Wed, October 2, 2024
Tue, October 1, 2024
Mon, September 30, 2024
Fri, September 27, 2024

Matthew Harrison Maintained VRT Xat Holdwith Increased Targetto 474on Oct 1st 2024

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. dwith-increased-targetto-474on-oct-1st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Matthew Harrison of Morgan Stanley, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold with Increased Target from $462 to $474 on, Oct 1st, 2024.

Matthew has made no other calls on VRTX in the last 4 months.



There are 15 other peers that have a rating on VRTX. Out of the 15 peers that are also analyzing VRTX, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Reiterated at Hold and Held Target at $431 on, Thursday, September 19th, 2024
  • Gena Wang of "Barclays" Downgraded from Buy to Hold and Increased Target to $509 on, Monday, August 5th, 2024
  • Joseph Stringer of "Needham" Reiterated at Hold on, Friday, July 26th, 2024


These are the ratings of the 12 analyists that currently disagree with Matthew


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $550 on, Monday, August 5th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $510 on, Monday, August 5th, 2024
  • Joon Lee of "Truist Securities" Reiterated at Strong Buy with Increased Target to $550 on, Monday, August 5th, 2024
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $600 on, Monday, August 5th, 2024
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $480 on, Friday, August 2nd, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $535 on, Friday, August 2nd, 2024
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $558 on, Friday, August 2nd, 2024
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Sell with Increased Target to $376 on, Wednesday, July 31st, 2024
  • Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Increased Target to $500 on, Tuesday, July 23rd, 2024
  • Steve Chesney of "Redburn Atlantic" Initiated at Strong Buy and Held Target at $545 on, Thursday, June 27th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $555 on, Monday, June 24th, 2024
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $550 on, Monday, June 17th, 2024